EP3923999A1 — Ultrasonic standing wave nebulization system
Assigned to Restec Solutions LLC · Expires 2021-12-22 · 4y expired
What this patent protects
A system of generating an aerosol, by: (a) placing a liquid into a liquid chamber in an ultrasonic nebulization system having a cylindrical aerosol production chamber received within a cylindrical master chamber, and having top and bottom ultrasonic transducers; (b) passing air u…
USPTO Abstract
A system of generating an aerosol, by: (a) placing a liquid into a liquid chamber in an ultrasonic nebulization system having a cylindrical aerosol production chamber received within a cylindrical master chamber, and having top and bottom ultrasonic transducers; (b) passing air up through the aerosol production chamber; and (c) producing acoustic standing waves above the surface of the liquid with the top and bottom ultrasonic transducers, thereby generating an aerosol of the liquid by action of the standing waves.
Drugs covered by this patent
- glycopyrrolate (Glycopyrrolate) · Yonsei University
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.